Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2020

Feb 20, 2020

32130_dirs_2020-02-20_8baff3b8-078e-42fd-b7c1-eb5e888bd47d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2020-02-18

Reporting Person: Novack David F (President & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-18 Common Stock F 23085 $5.03 Disposed 123899 Direct

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2: The reporting person is reporting the sale of 23,085 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 18, 2020.

F3: This transaction was executed in multiple trades at prices ranging from $4.97 to $5.14; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.

F4: Includes 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 14, 2020.